{"id":62192,"date":"2025-11-12T19:03:39","date_gmt":"2025-11-12T18:03:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/"},"modified":"2025-11-12T19:03:39","modified_gmt":"2025-11-12T18:03:39","slug":"brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/","title":{"rendered":"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn"},"content":{"rendered":"
\n

LYON, France & PITTSBURGH–(BUSINESS WIRE)–#Biotech<\/a>–Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of Olivera J. Finn, Distinguished Professor at the University of Pittsburgh School of Medicine<\/a>, to its Scientific Advisory Board (SAB).<\/p>\n

<\/a>
<\/a><\/p>\n

\nThis strategic addition strengthens Brenus\u2019 international SAB as the company advances its proprietary Stimulated Ghost Cell (SGC) platform<\/a> and lead candidate STC-1010<\/a> toward its next clinical milestones.<\/p>\n

\nGlobally recognized for her groundbreaking contributions to cancer immunology, Prof. Finn has led major discoveries in tumor antigens. She identified the MUC1 tumor antigen<\/a>, a cornerstone in cancer research, and discovered cyclin B1 as a promising target for anti-cancer immunotherapy. Over her career, she has authored more than 220 peer-reviewed publications and co-led extensive clinical trials across pancreatic, colon, breast, prostate, and lung cancers.<\/p>\n

\nShe also served as President of the American Association of Immunologists (AAI)<\/a> and is an active member of the American Association for Cancer Research (AACR)<\/a> and the Society for Immunotherapy of Cancer (SITC)<\/a>.<\/b> She has also served on NCI study sections and was a member of the National Cancer Institute\u2019s Board of Scientific Councilors, advising on strategic directions for cancer research in the U.S.<\/p>\n

\nHer achievements have earned her prestigious honors, including the AAI Lifetime Achievement Award (2016),<\/a> the AACR Lloyd Old Cancer Immunology Prize (2017),<\/a> and the SITC Richard V. Smalley Memorial Award (2019)<\/a>\u2014recognition reserved for clinicians and scientists who have made a profound contribution to cancer immunotherapy research.<\/p>\n

\n\u201cBrenus\u2019 Stimulated Ghost Cell platform is a breakthrough in addressing critical challenges in immunotherapy. I am eager to leverage my expertise to accelerate this science and help validate STC-1010 as a transformative therapy\u201d, said Prof. J.Finn.<\/p>\n

\nBrenus Pharma is currently advancing STC-1010, its first-in-class immunotherapy candidate, toward next steps in clinical development, including U.S. expansion. The SAB reflects Brenus\u2019 ambition to build a global network of scientific advisors supporting its mission to transform cancer treatment.<\/p>\n

\nAbout Brenus Pharma
\n
<\/b>Brenus Pharma develops an off-the-shelf platform advancing novel modalities in immuno-oncology. This cutting-edge precision technology mimics tumor protein expression and makes it visible to the immune system, enabling a multi-specific in vivo <\/i>immune response against evolving tumor cells.
\n
www.brenus-pharma.com<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\ncontact@brenus-pharma.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LYON, France & PITTSBURGH–(BUSINESS WIRE)–#Biotech–Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of Olivera J. Finn, Distinguished Professor at the University of Pittsburgh School of Medicine, to its Scientific Advisory Board (SAB). This strategic addition strengthens Brenus\u2019 international SAB as the company advances its proprietary Stimulated … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62192","6":"format-standard","7":"category-industry"},"yoast_head":"\nBrenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LYON, France & PITTSBURGH–(BUSINESS WIRE)–#Biotech–Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of Olivera J. Finn, Distinguished Professor at the University of Pittsburgh School of Medicine, to its Scientific Advisory Board (SAB). This strategic addition strengthens Brenus\u2019 international SAB as the company advances its proprietary Stimulated ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-12T18:03:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251112049028\/en\/2641727\/22\/Logo_Brenus_Blue.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn\",\"datePublished\":\"2025-11-12T18:03:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/\"},\"wordCount\":385,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112049028\\\/en\\\/2641727\\\/22\\\/Logo_Brenus_Blue.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/\",\"name\":\"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112049028\\\/en\\\/2641727\\\/22\\\/Logo_Brenus_Blue.jpg\",\"datePublished\":\"2025-11-12T18:03:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112049028\\\/en\\\/2641727\\\/22\\\/Logo_Brenus_Blue.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112049028\\\/en\\\/2641727\\\/22\\\/Logo_Brenus_Blue.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/","og_locale":"en_US","og_type":"article","og_title":"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn - Pharma Trend","og_description":"LYON, France & PITTSBURGH–(BUSINESS WIRE)–#Biotech–Brenus Pharma, a clinical-stage biotechnology company developing first-in-class in vivo immunotherapies for solid tumors, announced the appointment of Olivera J. Finn, Distinguished Professor at the University of Pittsburgh School of Medicine, to its Scientific Advisory Board (SAB). This strategic addition strengthens Brenus\u2019 international SAB as the company advances its proprietary Stimulated ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-12T18:03:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251112049028\/en\/2641727\/22\/Logo_Brenus_Blue.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn","datePublished":"2025-11-12T18:03:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/"},"wordCount":385,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251112049028\/en\/2641727\/22\/Logo_Brenus_Blue.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/","url":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/","name":"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251112049028\/en\/2641727\/22\/Logo_Brenus_Blue.jpg","datePublished":"2025-11-12T18:03:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251112049028\/en\/2641727\/22\/Logo_Brenus_Blue.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251112049028\/en\/2641727\/22\/Logo_Brenus_Blue.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/brenus-pharma-expands-its-global-scientific-advisory-board-with-us-immuno-oncology-expert-prof-olivera-j-finn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62192"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62192\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}